511
Participants
Start Date
July 20, 2018
Primary Completion Date
February 12, 2021
Study Completion Date
February 12, 2021
Midostaurin
Midostaurin was provided as 25 mg capsules 8PC, was supplied as double-blind in blister packs and taken orally.
Placebo
Placebo was provided as 25 mg soft gelatin capsules 8PC, was supplied as double-blind in blister packs and taken orally.
Chemotherapy
Along with the study drug/placebo, chemotherapy was given as well: either Daunorubicin or Idarubicin and Cytarabine - all taken by i.v.
Novartis Investigative Site, Vienna
Novartis Investigative Site, Vienna
Novartis Investigative Site, Sofia
Novartis Investigative Site, Antwerp
Novartis Investigative Site, Westmead
Novartis Investigative Site, Bern
Novartis Investigative Site, Prahran
Novartis Investigative Site, Woolloongabba
Novartis Investigative Site, Murdoch
Novartis Investigative Site, Bruges
Novartis Investigative Site, Zurich
Novartis Investigative Site, Roeselare
Novartis Investigative Site, Taipei
Novartis Investigative Site, Cáceres
Novartis Investigative Site, Torino
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Berlin
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Alessandria
Novartis Investigative Site, Bad Saarow
Novartis Investigative Site, Rostock
Novartis Investigative Site, Schwerin
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Milan
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Dijon
Novartis Investigative Site, Lübeck
Novartis Investigative Site, Kiel
Novartis Investigative Site, Bergamo
Novartis Investigative Site, Flensburg
Novartis Investigative Site, Brescia
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Piacenza
Novartis Investigative Site, Plzen-Bory
Novartis Investigative Site, Hanover
Novartis Investigative Site, Toulouse
Novartis Investigative Site, Paderborn
Novartis Investigative Site, Kuei Shan Chiang
Novartis Investigative Site, Giessen
Novartis Investigative Site, Vicenza
Novartis Investigative Site, Salamanca
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Braunschweig
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Seville
Novartis Investigative Site, Modena
Novartis Investigative Site, Nantes
Novartis Investigative Site, Bochum
Novartis Investigative Site, Essen Werden
Novartis Investigative Site, Valencia
Novartis Investigative Site, Duisburg
Novartis Investigative Site, Barakaldo
Novartis Investigative Site, Angers
Novartis Investigative Site, Osnabrück
Novartis Investigative Site, Zaragoza
Novartis Investigative Site, Eschweiler
Novartis Investigative Site, Bonn
Novartis Investigative Site, Mainz
Novartis Investigative Site, Siegen
Novartis Investigative Site, Lille
Novartis Investigative Site, Ancona
University of Chicago Medical Center ., Chicago
Novartis Investigative Site, Putzu City
Novartis Investigative Site, Bayonne
Novartis Investigative Site, Darmstadt
Novartis Investigative Site, Pescara
Novartis Investigative Site, Homburg
Novartis Investigative Site, Pierre-Bénite
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Stuttgart
Novartis Investigative Site, Taranto
Novartis Investigative Site, Paris
Novartis Investigative Site, Karlsruhe
Novartis Investigative Site, München
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Avignon
Novartis Investigative Site, Ulm
Novartis Investigative Site, Reggio Calabria
Novartis Investigative Site, Palermo
Novartis Investigative Site, Regensburg
Novartis Investigative Site, Catania
Novartis Investigative Site, Würzburg
Oregon Health and Science Univ, Portland
Novartis Investigative Site, Haifa
Novartis Investigative Site, Petah Tikva
Novartis Investigative Site, Tel Aviv
Dana Farber Cancer Institute, Boston
Novartis Investigative Site, CABA
Novartis Investigative Site, Linz
Novartis Investigative Site, Porto Alegre
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Brno - Bohunice
Novartis Investigative Site, Leipzig
Novartis Investigative Site, Zwickau
Novartis Investigative Site, Perugia
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Matsuyama
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Fukushima
Novartis Investigative Site, Gifu
Novartis Investigative Site, Fukuyama
Novartis Investigative Site, Tsukuba
Novartis Investigative Site, Isehara
Novartis Investigative Site, Nagasaki
Novartis Investigative Site, Okayama
Novartis Investigative Site, Hirakata
Novartis Investigative Site, Ōsaka-sayama
Novartis Investigative Site, Hamamatsu
Novartis Investigative Site, Shimotsuke
Novartis Investigative Site, Bunkyo Ku
Novartis Investigative Site, Bunkyo-ku
Novartis Investigative Site, Aomori
Novartis Investigative Site, Kyoto
Novartis Investigative Site, Osaka
Novartis Investigative Site, Yamagata
Novartis Investigative Site, Bergen
Novartis Investigative Site, Oslo
Novartis Investigative Site, Gdansk
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Porto
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Adana
Novartis Investigative Site, Ankara
Novartis Investigative Site, Aydin
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY